ABC | Volume 111, Nº4, Octuber 2018

Original Article Martins ACS Fractional flow reserve-guided strategy Arq Bras Cardiol. 2018; 111(4):542-550 15. Briasoulis A, PallaM, Mostafa A, Afonso L, Grines C. Fractional flow-guided management inpatientswithacutecoronarysyndromes:asystematicreview and meta-analysis. Int J Cardiol. 2015;187:334-7. 16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88. 17. Echavarría-Pinto M, van de Hoef TP, Serruys PW, Piek JJ, Escaned J. Facing the complexity of ischaemic heart disease with intracoronary pressure and flow measurements: beyond fractional flow reserve interrogation of the coronary circulation. Curr Opin Cardiol 2014;29(6):564-70. 18. ToninoPA,DeBruyneB,PijlsNH,SiebertU,IkenoF,van’tVeerM,etal;FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213-24. 19. Depta JP, Patel JS, Novak E, Masrani SK, Raymer D, Facey G, et al. Outcomes of coronarystenosesdeferredrevascularizationforborderlineversusnonborderline fractionalflowreservevalues.AmJCardiol2014;113(11):1788-93. 20. Layland J, Oldroyd KG, Curzen N, Sood A, Balachandran K, Das R, et al; FAMOUS–NSTEMI investigators. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial. Eur Heart J. 2015;36(2):100-11. 21. Kolh P, Windecker S. ESC/EACTS myocardial revascularization guidelines 2014. Eur Heart J. 2014;35(46):3235-6. 22. Niccoli G, Indolfi C, Davies JE. Evaluation of intermediate coronary stenoses in acute coronary syndromes using pressure guidewire. Open Heart. 2017;4(2):e000431. 23. Lopez-Palop R, Carrillo P, Torres F, Lozano I, Frutos A, Avanzas P, et al. Results of fractional flow reserve measurement to evaluate nonculprit coronary artery stenoses in patients with acute coronary syndrome. Rev Esp Cardiol (Engl Ed). 2012;65(2):164-70. 24. Sels JW, Tonino PA, Siebert U, FearonWF, Van’t Veer M, De Bruyne B, et al. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus angiography forMultivessel evaluation) study. JACCCardiovasc Interv. 2011;4(11):1183-9. 25. Masrani Mehta S, Depta JP, Novak E, Patel JS, Patel Y, Raymer D, et al. Association of lower fractional flow reserve values with higher risk of adverse cardiac events for lesions deferred revascularization among patients with acute coronary syndrome. J AmHeart Assoc. 2015;4(8):e002172. 26. Picchi A, AntonioMaria Leone AM, Zilio F, Enrico Cerrato E, D’Ascenzo F, Fineschi M, et al. Outcome of coronary lesions with deferred revascularization due to negative fractional flow reserve in subjects with acute coronary syndrome. Int J Cardiol. 2017 Mar 1;230:335-8. 27. Leesar MA, Abdul-Baki T, Akkus NI, Sharma A, Kannan T, Bolli R. Use of fractional flow reserve versus stress perfusion scintigraphy after unstable angina. Effect on duration of hospitalization, cost, procedural characteristics, and clinical outcome. J Am Coll Cardiol. 2003;41(7):1115-21. 28. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356(8):830-40. 29. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111(3):363-8. 30. De Bruyne B, Pijls NH, Bartunek J, Kulecki K, Bech JW, De Winter H, et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation. 2001;104(2):157-62. 31. EngstrømT, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Holmvang L, et al; DANAMI-3—PRIMULTI Investigators. Complete revascularization versus treatment of the culprit lesion only in patients with STsegment elevation myocardial infarction andmultivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386(9994):665-71. 32. Smits PC, Abdel-Wahab M, Neumann FJ, Boxma-de Klerk BM, Lunde K, Schotborgh CE, et al; Compare-acute investigators. fractional flow reserve- guided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017;376(13):1234-44. 33. Alcock RF, Yong AS, Ng AC, Chow V, Cheruvu C, Aliprandi-Costa B, et al. Acute coronary syndrome and stable coronary artery disease: are they so different? Long-termoutcomes in a contemporary PCI cohort. Int J Cardiol. 2013;167(4):1343-6. 34. HakeemA, Edupuganti MM, Almomani A, Pothineni NV, Payne J, Abualsuod AM, et al. Long-term prognosis of deferred acute coronary syndrome lesions based on nonischemic fractional flow reserve. Am Coll Cardiol. 2016;68(11):1181-91. 35. Morrow DA. Cardiovascular risk prediction in patients with stable and unstable coronary heart disease. Circulation. 2010;121(24):2681-91. 36. Mahaffey KW, Wojdyla DM, Pieper KS, Tricoci P, Alexander JH, Lincoff AM, etal.Comparisonofclinicaltrialoutcomepatterns inpatients followingacute coronary syndromes and in patients with chronic stable atherosclerosis. Clin Cardiol. 2014;37(6):337-42. 37. Lee JM, Choi KH, Koo BK, Shin ES, Nam CW, Doh JH, et al. Prognosis of deferred non-culprit lesions according to fractional flow reserve in patients with acute coronary syndrome. Eurointervention. 2017;13(9):e1112-9. 38. VanBelleE,BaptistaSB,RaposoL,HendersonJ,RioufolG,SantosL,etal;PRIME- FFR Study Group. Impact of Routine Fractional Flow Reserve onManagement Decision and 1-Year Clinical Outcome of Patients With Acute Coronary Syndromes: PRIME-FFR (Insights From the POST-IT [Portuguese Study on the Evaluation of FFR-Guided Treatment of CoronaryDisease] andR3F [French FFR Registry]IntegratedMulticenterRegistries-ImplementationofFFR[FractionalFlow Reserve] inRoutinePractice).CircCardiovascInterv.2017;10(6).pii:e004296 39. Van Belle E, Rioufol G, Pouillot C, Cuisset T, Bougrini K, Teiger E, et al; Investigators of the Registre Français de la FFR–R3F. Outcome impact of coronaryrevascularizationstrategyreclassificationwithfractionalflowreserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry. Circulation. 2014;129(2):173-85. 40. Baptista SB, Raposo L, Santos L, Ramos R, Calé R, Jorge E, et al. Impact of routine fractional flow reserve evaluation during coronary angiography on managementstrategyandclinicaloutcome:one-yearresultsoftheprospective POST-ITmulticenterregistry.CircCardiovascInterv.2016;9(7).pii:e003288. 41. FearonWF, De Bruyne B, Pijls NHJ. Fractional flow reserve in acute coronary syndromes. J Am Coll Cardiol. 2016;68(11):1192-4. 42. Rodés-Cabau J, Gutiérrez M, Courtis J, Larose E, Déry JP, Côté M, et al. Importance of diffuse atherosclerosis in the functional evaluation of coronary stenosis in the proximal-mid segment of a coronary artery by myocardial fractional flow reserve measurements. Am J Cardiol 2011;108(4):483-90. 43. Adjedj J, Toth GG, Johnson NP, Pellicano M, Ferrara A, Floré V, et al. Intracoronary adenosine: dose-response relationshipwith hyperemia. JACC Cardiovasc Interv. 2015;8(11):1422-30. 44. Esen AM, Acar G, Esen O, Emiroglu Y, Akcakoyun M, Pala S, et al. The prognostic value of combined fractional flow reserve and TIMI frame count measurements in patients with stable angina pectoris and acute coronary syndrome. J Interv Cardiol. 2010;23(5):421-8. 549